AstraZeneca’s new cancer medication Imjudo launched in UAE
Abu Dhabi, UAE -- AstraZeneca has announced the launch of its revolutionary cancer medication, IMJUDO® (tremelimumab) in the UAE.The launch makes the UAE one of the first countries in the Middle East to receive access to the medication that marks a significant advancement in the treatment of cancer.Clinical trials have...
This is a temporary backup site for TRENDS MENA while our primary website is being restored following a regional disruption affecting AWS cloud infrastructure in the GCC.
tremelimumab
AD Ports Group 2024 net profit $484m
The Group's revenue increased 48 percent year-on-year.
TAQA net income $1.93bn in 2024
The company's revenues increased 6.7 percent year-on-year.
ADNOC L&S 2024 net profit $756m
The company's revenue increased by 29 percent to $3.54 billion.
ADNOC Distribution 2024 net profit down 7%
Minus UAE corporate tax, it would have grown by 2.4% to $725m
Maaden raises $1.25bn in sukuk offering
The Sukuk were offered in a five-year and a 10-year tranche.
